ARGENX SE revenue for the last year amounted to 46.95 B MXN, the most of which — 45.67 B MXN — came from its highest performing source at the moment, Antibody-based Medicines, the year earlier bringing 20.83 B MXN. The greatest contribution to the revenue figure was made by United States — last year it brought ARGENX SE 39.53 B MXN, and the year before that — 18.29 B MXN.